EPO’s Boards of Appeal Upholds Arecor’s Patent against GSK’s Opposition
shot by IP News Shots / 5:47 pm on 12 October, 2021
The Boards of Appeal of the European Patent Office (EPO) upheld Arecor Therapeutics plc polysaccharide vaccines patent against. Arecor’s win will result in a powerful patent portfolio and protection of its Arestat technology platform. The novel composition of polysaccharide vaccines prevents infections such as meningitis or pneumonia and it will ensure no loss of potency.
Industry: Biotechnology, Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Business Weekly
PTAB Rules in Favor of Liquidia in IPR against United Therapeutics Patent
shot by IP News Shots / 5:04 pm on 11 October, 2021
The Patent Trial and Appeal Board (PTAB) has awarded a win to Liquidia Corporation in an inter partes review (IPR) proceeding against United Therapeutics Corporation (UTC). PTAB has discovered that seven out of nine claims were unpatentable related to UTC’s Tyvaso patent. Liquidia President and CEO shared his contentment with PTAB’s ruling and is keen on defending the claims against their right to commercialize LIQ861.
Industry: Biotechnology, Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Law360
U.S. Court Accepts Motion to Dismiss Medytox and Daewoong Patent Row
shot by IP News Shots / 5:47 pm on 08 October, 2021
Medytox Inc. had submitted a motion to dismiss the case against Daewoong Pharmaceutical Co. with the U.S. District Court for the Eastern District of Virginia, which has been accepted by the judge. Medytox was involved in a long-running intellectual property (IP) legal battle against Daewoong over botulinum toxin strain. Medytox had sued Daewoon in the Eastern District Court of Virginia and the U.S. District Court for the Central District of California.
Industry: Biotechnology, Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Yonhap News Agency
Synthego Seeks Court’s Declaration, Claims Non-infringement of CRISPR Patents
shot by IP News Shots / 7:10 pm on 07 October, 2021
Synthego Corp. has lodged a declaratory judgement lawsuit in the U.S. District Court for the Northern District of California seeking the court’s declaration that Synthego products related to the breakthrough gene-editing technology CRISPR do not infringe Agilent’s two patents.
Industry: Biotechnology | News Category: Litigations | Type of IP: Patent
Read more at Law360
Moderna Seeks CAFC’s Help for Protection against COVID-19 Vaccine Patent Lawsuits
shot by IP News Shots / 6:53 pm on 07 October, 2021
Moderna, Inc. is seeking the U.S. Court of Appeals for the Federal Circuit’s (CAFC) aid in invalidating two of Arbutus Biopharma Corp.’s patents related to drug-delivery technology. Moderna is concerned with COVID-19 vaccines’ vulnerability to patent infringement lawsuits and its future. The company asserts considerable risk from the rival Arbutus’ accusation of Moderna’s infringement of drug-delivery technology patents.
Industry: Biotechnology, Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Bloomberg Law
Allergan Files Patent Infringement Lawsuit against Revance over Botox Patents
shot by IP News Shots / 5:32 pm on 06 October, 2021
Allergan, Inc. has filed a patent infringement lawsuit against Revance Therapeutics, Inc. over its botox patents. Allergan has asserted that Revance’s frown-line injection daxibotulinumtoxinA infringes several botox patents owned by the plaintiff. Revance was seeking the U.S. Food and Drug Administration’s (FDA) permission for the injection which was delayed due to the pandemic. Allergan is seeking the court’s verdict on rival’s infringement and damages.
Industry: Biotechnology, Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Fierce Pharma